Diabetic Retinopathy-A Review

Area of Science:

• Ophthalmology
• Endocrinology
• Vascular Biology

Background:

• Diabetic retinopathy is a leading cause of blindness, stemming from microvascular damage due to hyperglycemia.
• It progresses silently, often with no early symptoms, affecting vision through macular edema and retinal damage.
• Risk increases with diabetes duration, and it poses specific concerns during pregnancy.

Purpose of the Study:

• To review the current understanding of diabetic retinopathy pathophysiology.
• To explore the roles of specific biomarkers like ALR, AGEs, VEGF, EPO, and eNOS.
• To analyze current clinical treatments and novel findings in diabetic retinopathy research.

Main Methods:

• Literature review focusing on pathophysiology, genetics, and molecular mechanisms.
• Analysis of diagnostic methods including ophthalmoscopy, fundus photography, and angiography.
• Examination of clinical trials and laboratory findings.

Main Results:

• Diabetic retinopathy involves complex pathophysiology driven by hyperglycemia and microangiopathy.
• Several key molecular factors (ALR, AGEs, VEGF, EPO, eNOS) are implicated in its progression.
• Current diagnostic tools and treatments aim to manage the condition and prevent vision loss.

Conclusions:

• A comprehensive understanding of diabetic retinopathy's pathophysiology is essential for developing effective interventions.
• Continued research into novel treatments and early diagnostic markers is critical.
• Regular eye examinations are vital for diabetic patients, especially pregnant women, to prevent vision impairment.